—Researchers recently set out to learn which factors predict rapid decline in patients with autosomal dominant polycystic kidney disease (ADPKD), and how this information could help clinicians ...

People with autosomal dominant polycystic kidney disease (ADPKD) are at a high risk of developing kidney failure during their lives. Although there are many strategies that can be used to help ...

BOSTON--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today provided updates on multiple kidney diseases in its pipeline ...

Autosomal dominant polycystic kidney disease (ADPKD) is the most common, potentially lethal genetic disorder characterized by the progressive enlargement of numerous fluid-filled cysts and the ...

SonoThera to Present at ASN Kidney Week 2024 Demonstrating the Potential of Novel Nonviral Ultrasound-Mediated Gene Therapy ...

Regulus (RGLS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from ...

and drugs that target the root genetic causes of APOL1-mediated kidney disease (AMKD), myotonic dystrophy type 1 (DM1), and autosomal dominant polycystic kidney disease (ADPKD). In the second ...

Dr. Allen Davidoff, PhD., Chief Executive Officer of XORTX commented, “The application of genetic diagnostic tools and recent pioneering discoveries in autosomal dominant polycystic kidney disease ...

Rossetti S, Consugar MB, Chapman AB, et al.: Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2007; 18: 2143–60 CrossRef CrossRef e3. Hateboer N, v ...

A review of the 2024 EAU guideline update on urolithiasis emphasizes differential diagnosis and tailored evaluation.

The newly acquired funds will be strategically used to advance the clinical trials of RN-014, our promising treatment in Phase II trials for Autosomal Dominant Polycystic Kidney Disease (ADPKD), and ...

Native nephrectomy in patients with autosomal dominant polycystic kidney disease in the kidney transplant program - single-center retrospective results of 2000-2020.